By David Wainer
The broader stock market is suffering losses after President Trump's tariff announcement over the weekend. But one group was insulated by separate comments made by Trump on Friday.
Health insurers with a focus on Medicaid saw gains Monday after Donald Trump signaled he might protect the program, despite Republican efforts to pursue spending cuts.
When asked about potential budget reductions on Friday, Trump said the administration would "love and cherish" Social Security, Medicare and Medicaid, according to Politico. His mention of Medicaid was notable, as he has in the past omitted it when discussing the programs his administration wouldn't touch.
Shares of Medicaid-focused insurers Molina Healthcare, Elevance Health, and Centene each rose more than 1.5% in response.
With the GOP in control of Congress and the White House, expectations have grown that government insurance programs like Affordable Care Act exchanges and Medicaid will be cut by Republicans looking for ways to pay for tax cuts.
Concerns over Medicaid's future intensified last week when the Trump administration implemented a freeze on grants and federal aid. While the freeze explicitly exempted Medicare and Social Security, it made no mention of Medicaid and some blamed that for a temporary outage to the program.
But Trump's remarks on Friday suggest a potential buffer for Medicaid.
"We're not going to do anything with that unless we can find some abuse or waste," Trump said. "The people won't be affected. It will only be more effective and better."
This analysis comes from the Journal's Heard on the Street team. Subscribe to their free daily afternoon newsletter here.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
February 03, 2025 12:56 ET (17:56 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。